Consensus Estimates as of April 14, 2025

in € mQ1 2025 EChange in € mQ2 2025 EChange in € mQ3 2025 EChange in € mQ4 2025 EChange in € mFY 2025 EChange in € mFY 2026 EChange in € mFY 2027 EChange in € m
Group Net sales1,167-11,19101,169-41,15504,70904,84604,947-20
- Basic Chemicals, Sales70507130718072702,86402,916-53,0150
- Performance Chemicals, Sales4640469-6456-244301,829-101,869-211,927-5
- Corporate, Sales30203030100100100
Group EBITDA25002670260025601,039-11,083-81,136-6
- Basic Chemicals, EBITDA1930195-11970195-2776-13813-9850-7
- Performance Chemicals, EBITDA75091084-2780335-3343-3347-6
- Corporate, EBITDA-200-200-200-200-800-900-680
Free cash flow to Solvay shareholders from continuing operations931102038088-173120381-84100

Provided by

Vara Research

Disclaimer

This document has been issued by Vara Research GmbH for information purposes only and is not intended to constitute investment advice. It is based on estimates and forecasts of various analysts regarding revenues, earnings and business developments of the relevant company. The company did not participate in the compilation of the estimates and it does not endorse them. Such estimates and forecasts cannot be independently verified by reason of the subjective character. Vara Research GmbH gives no guarantee, representation or warranty and is not responsible or liable as to its accuracy and completeness.